(Q44659070)

5 December 2017

title

Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis (English)

1 reference

5 December 2017

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.TUBE.2003.07.001

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.TUBE.2003.07.001

3 April 2024

author name string

Rajesh Pandey

1

1 reference

5 December 2017

Sadhna Sharma

3

1 reference

5 December 2017

A. Zahoor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623168

3 April 2024

G. K. Khuller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623168

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623168

3 April 2024

publication date

1 January 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S1472979203000763?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.TUBE.2003.07.001

https://api.elsevier.com/content/article/PII:S1472979203000763?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.TUBE.2003.07.001

3 April 2024

1 reference

5 December 2017

volume

83

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

373-378

1 reference

Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Risk of tuberculosis among healthcare workers: can tuberculosis be considered as an occupational disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Production and characterization of a budesonide nanosuspension for pulmonary administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Defining the drug incorporation properties of PLA-PEG nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Biologically erodable microspheres as potential oral drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2003.07.001

Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids

7 January 2021

14

1 reference

https://api.crossref.org/works/10.1016/J.TUBE.2003.07.001

3 April 2024

Identifiers

1 reference

5 December 2017

1 reference